Previous close | 2.2500 |
Open | 2.2500 |
Bid | 2.1000 |
Ask | 2.4000 |
Strike | 57.50 |
Expiry date | 2026-01-16 |
Day's range | 2.2500 - 2.4300 |
Contract range | N/A |
Volume | |
Open interest | 897 |
Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2024 Results Key Financial Results Revenue: US$11.9b (up 4.7% from 1Q...
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
PRINCETON, N.J., April 26, 2024--CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine....